{"cik":1990550,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"Ambrx Biopharma, Inc.","units":{"USD":[{"end":"2022-12-31","val":16660000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q4I"},{"end":"2023-09-30","val":18268000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3I"}]}}